Search for: "KV Pharmaceuticals"
Results 41 - 60
of 92
Sort by Relevance
|
Sort by Date
20 Oct 2010, 1:20 pm
KV Pharmaceutical Co., 2010 WL 59125 (E.D. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
4 Aug 2010, 12:21 am
Mylan Pharmaceuticals Inc. [read post]
29 Jul 2010, 6:24 am
Consumers can be hurt by lax manufacturing practices, as KV Pharmaceutical here in St. [read post]
27 May 2010, 6:51 am
Within the last two months, I've written about three other companies whose manufacturing practices have been under FDA's scrutiny, including McNeil Pharmaceuticals, Teva Pharmaceuticals and KV Pharmaceutical. [read post]
6 May 2010, 7:10 am
Last month, I wrote about the legal and financial troubles at Ethex Corp., whose parent company is KV Pharmaceuticals here in St. [read post]
13 Apr 2010, 7:30 am
KV Pharmaceutical Co., C.A. [read post]
9 Apr 2010, 6:10 am
KV Pharmaceuticals recalled the defective morphine tablets the next month. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
26 Feb 2010, 6:11 am
Zambri, founding partner The AP reported that "Drugmaker KV Pharmaceutical Co. says it will shut down its Ethex generic division, plead guilty to criminal charges" that the company failed to immediately notify "regulators of safety hazards. [read post]
25 Feb 2010, 2:18 pm
From a February 25, 2010 article, "KV Pharmaceutical to plead guilty, pay $27.6M, close generics business", published by the St. [read post]
26 Jan 2010, 3:33 pm
On November 7, 2008 Ethex Corporation, a subsidiary of KV Pharmaceuticals, issued a nationwide recall of five of its generic drugs. [read post]
18 Jan 2010, 1:02 pm
Two months ago we reported that Citigroup Global Markets, Inc. had asked a New York court to dismiss a $72 million lawsuit filed against it by KV Pharmaceutical Co. [read post]
11 Jan 2010, 6:00 am
KV Pharmaceutical Co., No. 4:09CV00588SNLJ, slip op. [read post]
1 Dec 2009, 9:39 am
KV Pharmaceutical Corp., 2008 WL 2937415 (D.N.J. 2008). [read post]
31 Oct 2009, 4:06 pm
October 31, 2009 – A summary review of environmental law settlements, decisions, regulatory actions and lawsuits filed during the past week. [read post]
12 Oct 2009, 12:38 pm
Citigroup Global Market, Inc. has filed a motion to dismiss an action against it by KV Pharmaceuticals Co. arising out of sales of auction rate securities, according to an August 25 article in Law360 by Christine Caufield entitled "Citigroup Argues KV Pharma Knew ARS Risks. [read post]
23 Sep 2009, 4:00 am
(Intellectual Property Watch) Products Coversyl (Perindopril) - Australia: FCA decision a reminder to review issued patent claims in view of newly emerged prior art before filing suit: Apotex Pty Ltd v Les Laboratoires Servier (Patent Baristas) Duac (Clindamycin, Benzoyl) – Perrigo acquires KV Pharmaceutical’s first to file ANDA for generic Duac gel (GenericsWeb) Mircera (Recombinant erythropoietin) – US: CAFC: Section 121 ‘safe… [read post]
4 Sep 2009, 12:11 pm
KV Pharmaceutical Company, C.A. 08-223-JJF (D. [read post]
17 Jun 2009, 9:58 pm
By Suresh Pillai -- Settlement Announced in Oxycontin ® Litigation KV Pharmaceutical Co. announced a settlement in its litigation with Purdue Pharma LP over the painkiller Oxycontin ® (see "Court Report," June 11, 2007). [read post]
